National Bank of Canada
ONEM

National Bank of Canada’s 1Life Healthcare ONEM Stock Holding History

National Bank of Canada’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-354,850
Closed -$5.93M – 2932
2022
Q4 		$5.93M Hold
354,850
– – 0.02% 558
2022
Q3 		$6.09M Buy
354,850
+353,000
+19,081% +$5.54M 0.03% 482
2022
Q2 		$15K Hold
1,850
– – ﹤0.01% 2163
2022
Q1 		$20K Hold
1,850
– – ﹤0.01% 2195
2021
Q4 		$33K Buy
+1,850
New +$35.9K ﹤0.01% 2017

National Bank of Canada's ONEM Position: Q1 2023 in Review

National Bank of Canada sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 354,850 shares — an estimated $5.93M sold.

National Bank of Canada first reported a position in ONEM in Q4 2021 and held it in 5 quarters. The position peaked at $6.09M in Q3 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • National Bank of Canada reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • National Bank of Canada sold 354,850 1Life Healthcare shares in Q1 2023, an estimated $5.93M.
  • National Bank of Canada first reported a position in 1Life Healthcare in Q4 2021 and held it in 5 quarters.
  • National Bank of Canada's 1Life Healthcare position peaked at $6.09M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on National Bank of Canada's 13F filing for Q1 2023, filed 12 Apr 2023.